RecruitingNot ApplicableNCT06108830

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

Effect of Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients Undergoing Gastroenteroscopies


Sponsor

Tianjin Medical University General Hospital

Enrollment

400 participants

Start Date

Dec 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To explore the effects of esketamine combined with remimazolam on postoperative sleep disturbance and anxiety in surgical patients undergoing gastroenteroscopies


Eligibility

Min Age: 20 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether using a combination of esketamine and remimazolam (both anesthesia-related medications) during or after elective surgery helps reduce sleep problems and anxiety that patients sometimes experience after an operation. **You may be eligible if...** - You are between 20 and 65 years old - You are scheduled for elective (non-emergency) surgery - You have a BMI between 19 and 30 - You are in generally good to moderate health (ASA class I–III) **You may NOT be eligible if...** - You have a history of neurological disease, chronic pain, or long-term opioid use - You have heart disease, severe high blood pressure, asthma, or significant liver/kidney problems - You have a history of gastrointestinal disease (like Crohn's or peptic ulcer) - You are pregnant or breastfeeding - You are allergic to anesthesia medications, opioids, or NSAIDs - You participated in another drug trial in the past 4 weeks Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEsketamine

Patients undergoing gastroenteroscopies were given propofol 2 to 3mg/kg and esketamine 0.2mg/kg before the procedure began

DRUGRemimazolam

Patients undergoing gastroenteroscopies were given propofol 2 to 3mg/kg and remimazolam 0.15mg/kg before the procedure began

DRUGEsketamine and remimazolam

Patients undergoing gastroenteroscopies were given propofol 2 to 3mg/kg and remimazolam 0.15mg/kg before the procedure began

DRUGnormal saline

Patients undergoing gastroenteroscopies were given propofol 2-3mg/kg and 10ml 0.9% saline before the procedure began


Locations(1)

Tianjin Medical University General Hospital

Tianjin, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06108830


Related Trials